Amlodipine-induced immune thrombocytopenia

Vox Sang. 2004 Jan;86(1):75-6. doi: 10.1111/j.0042-9007.2004.00376.x.

Abstract

Background and objectives: Drug-induced thrombocytopenia is a serious, but rare, side-effect of treatment with a number of drugs. In this report, we investigate the suspicion that amlodipine, a calcium-channel blocker, was responsible for immune thrombocytopenia in a 79-year-old patient.

Patient and methods: Our patient experienced two attacks of thrombocytopenic purpura after 10 years of treatment with amlodipine. Antibodies to platelets were tested by standard methods.

Results: Initially, the platelet count increased owing to treatment with prednisolone and intravenous immunoglobulin G, but decreased shortly after discontinuation of this treatment. The patient's serum was found to contain amlodipine-dependent antibodies to platelets, and he recovered after stopping the drug.

Conclusions: Amlodipine can induce immune thrombocytopenia, which may strongly resemble autoimmune thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amlodipine / adverse effects*
  • Amlodipine / immunology
  • Antibodies / blood
  • Blood Platelets / immunology
  • Diagnosis, Differential
  • Humans
  • Male
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / immunology*

Substances

  • Antibodies
  • Amlodipine